Cord Blood America, Inc. (CBAI)
August 27, 2007 - Matthew Schissler, CEO, is featured in an exclusive interview with Francis Gaskins posted at http://www.streetiq.com/ .
In the interview, Mr. Schissler discusses the Company’s strong recent financial results, with six month revenues topping $4.04 million. Cord Blood America’s CEO said he is particularly pleased with the excellent gross profit results, totaling $1.4 million for the first half of 2007, and providing the Company significantly more working capital.
The interview also touches on the Company’s recent accretive acquisition of the assets of an umbilical cord blood stem cell company in South Carolina, a history of the growth of CBAI, and reasons why it is undervalued. Also, Mr. Schissler discusses why it is important for families to consider umbilical cord blood stem cell storage and the many possible therapeutic uses of these cells that could grow this sector dramatically.
In the interview, Mr. Schissler discusses the Company’s strong recent financial results, with six month revenues topping $4.04 million. Cord Blood America’s CEO said he is particularly pleased with the excellent gross profit results, totaling $1.4 million for the first half of 2007, and providing the Company significantly more working capital.
The interview also touches on the Company’s recent accretive acquisition of the assets of an umbilical cord blood stem cell company in South Carolina, a history of the growth of CBAI, and reasons why it is undervalued. Also, Mr. Schissler discusses why it is important for families to consider umbilical cord blood stem cell storage and the many possible therapeutic uses of these cells that could grow this sector dramatically.
Labels: analysis, ceo, gaskins, interview, Medical, stem cell, stock pick, technology
posted by streetiq at 7:37 AM
0 Comments:
Post a Comment
<< Home